nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—brain cancer	0.697	1	CbGaD
Sitaxentan—CYP3A4—Temozolomide—brain cancer	0.0459	0.486	CbGbCtD
Sitaxentan—CYP3A4—Lomustine—brain cancer	0.039	0.414	CbGbCtD
Sitaxentan—CYP3A4—Etoposide—brain cancer	0.00944	0.0999	CbGbCtD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00797	0.133	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0057	0.0952	CbGpPWpGaD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00553	0.0922	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00395	0.066	CbGpPWpGaD
Sitaxentan—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00223	0.0371	CbGpPWpGaD
Sitaxentan—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00203	0.0338	CbGpPWpGaD
Sitaxentan—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00173	0.0288	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—TRPC6—brain cancer	0.00141	0.0235	CbGpPWpGaD
Sitaxentan—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—brain cancer	0.00123	0.0204	CbGpPWpGaD
Sitaxentan—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00107	0.0178	CbGpPWpGaD
Sitaxentan—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00103	0.0172	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—TRPC6—brain cancer	0.00101	0.0168	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—SMO—brain cancer	0.000739	0.0123	CbGpPWpGaD
Sitaxentan—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000734	0.0123	CbGpPWpGaD
Sitaxentan—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000643	0.0107	CbGpPWpGaD
Sitaxentan—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000618	0.0103	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—PTCH2—brain cancer	0.000599	0.01	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—TRPC6—brain cancer	0.00059	0.00985	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000528	0.00881	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—OR4C12—brain cancer	0.000526	0.00877	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—OR14C36—brain cancer	0.000526	0.00877	CbGpPWpGaD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000514	0.00858	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—OR4C12—brain cancer	0.000477	0.00797	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—OR14C36—brain cancer	0.000477	0.00797	CbGpPWpGaD
Sitaxentan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000444	0.00741	CbGpPWpGaD
Sitaxentan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000442	0.00737	CbGpPWpGaD
Sitaxentan—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000438	0.00731	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—PTCH2—brain cancer	0.000429	0.00716	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—TRPC6—brain cancer	0.000422	0.00705	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000421	0.00702	CbGpPWpGaD
Sitaxentan—Pancytopenia—Hydroxyurea—brain cancer	0.000386	0.00259	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000381	0.00255	CcSEcCtD
Sitaxentan—Dysuria—Hydroxyurea—brain cancer	0.000381	0.00255	CcSEcCtD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000378	0.00631	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—OR14C36—brain cancer	0.000376	0.00628	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—OR4C12—brain cancer	0.000376	0.00628	CbGpPWpGaD
Sitaxentan—Body temperature increased—Lomustine—brain cancer	0.000372	0.0025	CcSEcCtD
Sitaxentan—Alopecia—Procarbazine—brain cancer	0.000372	0.00249	CcSEcCtD
Sitaxentan—Infestation NOS—Hydroxyurea—brain cancer	0.000363	0.00243	CcSEcCtD
Sitaxentan—Infestation—Hydroxyurea—brain cancer	0.000363	0.00243	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00036	0.00601	CbGpPWpGaD
Sitaxentan—Tension—Procarbazine—brain cancer	0.00036	0.00241	CcSEcCtD
Sitaxentan—Ataxia—Carmustine—brain cancer	0.000358	0.0024	CcSEcCtD
Sitaxentan—Nervousness—Procarbazine—brain cancer	0.000356	0.00239	CcSEcCtD
Sitaxentan—Stomatitis—Hydroxyurea—brain cancer	0.000354	0.00237	CcSEcCtD
Sitaxentan—Liver function test abnormal—Carmustine—brain cancer	0.000351	0.00236	CcSEcCtD
Sitaxentan—Ataxia—Temozolomide—brain cancer	0.000346	0.00232	CcSEcCtD
Sitaxentan—Tremor—Procarbazine—brain cancer	0.000343	0.0023	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000343	0.0023	CcSEcCtD
Sitaxentan—Dehydration—Temozolomide—brain cancer	0.000342	0.00229	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—OR14C36—brain cancer	0.000342	0.0057	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—OR4C12—brain cancer	0.000342	0.0057	CbGpPWpGaD
Sitaxentan—Anaemia—Procarbazine—brain cancer	0.000339	0.00227	CcSEcCtD
Sitaxentan—Dry skin—Temozolomide—brain cancer	0.000337	0.00226	CcSEcCtD
Sitaxentan—Muscular weakness—Carmustine—brain cancer	0.000336	0.00225	CcSEcCtD
Sitaxentan—Breast disorder—Temozolomide—brain cancer	0.000332	0.00223	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000331	0.00222	CcSEcCtD
Sitaxentan—Leukopenia—Procarbazine—brain cancer	0.000328	0.0022	CcSEcCtD
Sitaxentan—Haemoglobin—Hydroxyurea—brain cancer	0.000327	0.00219	CcSEcCtD
Sitaxentan—Haemorrhage—Hydroxyurea—brain cancer	0.000326	0.00218	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Etoposide—brain cancer	0.000325	0.00218	CcSEcCtD
Sitaxentan—Muscular weakness—Temozolomide—brain cancer	0.000324	0.00217	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000324	0.00217	CcSEcCtD
Sitaxentan—Pancytopenia—Carmustine—brain cancer	0.000312	0.00209	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—SHH—brain cancer	0.000309	0.00515	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PTCH2—brain cancer	0.000308	0.00513	CbGpPWpGaD
Sitaxentan—Bronchitis—Temozolomide—brain cancer	0.000306	0.00205	CcSEcCtD
Sitaxentan—Dry mouth—Procarbazine—brain cancer	0.000305	0.00204	CcSEcCtD
Sitaxentan—Pancytopenia—Temozolomide—brain cancer	0.000302	0.00202	CcSEcCtD
Sitaxentan—Cardiac failure—Etoposide—brain cancer	0.000302	0.00202	CcSEcCtD
Sitaxentan—Confusional state—Procarbazine—brain cancer	0.000301	0.00202	CcSEcCtD
Sitaxentan—Vomiting—Lomustine—brain cancer	0.000299	0.00201	CcSEcCtD
Sitaxentan—Oedema—Procarbazine—brain cancer	0.000299	0.002	CcSEcCtD
Sitaxentan—Dysuria—Temozolomide—brain cancer	0.000297	0.00199	CcSEcCtD
Sitaxentan—Infection—Procarbazine—brain cancer	0.000297	0.00199	CcSEcCtD
Sitaxentan—Hyperglycaemia—Carmustine—brain cancer	0.000297	0.00199	CcSEcCtD
Sitaxentan—Angiopathy—Hydroxyurea—brain cancer	0.000296	0.00198	CcSEcCtD
Sitaxentan—Pollakiuria—Temozolomide—brain cancer	0.000294	0.00197	CcSEcCtD
Sitaxentan—Thrombocytopenia—Procarbazine—brain cancer	0.000293	0.00196	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—PTCH1—brain cancer	0.000293	0.00488	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—SMO—brain cancer	0.000293	0.00488	CbGpPWpGaD
Sitaxentan—Tachycardia—Procarbazine—brain cancer	0.000292	0.00196	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Temozolomide—brain cancer	0.00029	0.00195	CcSEcCtD
Sitaxentan—Renal failure—Carmustine—brain cancer	0.000288	0.00193	CcSEcCtD
Sitaxentan—Alopecia—Hydroxyurea—brain cancer	0.000288	0.00193	CcSEcCtD
Sitaxentan—Weight decreased—Temozolomide—brain cancer	0.000288	0.00193	CcSEcCtD
Sitaxentan—Hyperglycaemia—Temozolomide—brain cancer	0.000287	0.00192	CcSEcCtD
Sitaxentan—Stomatitis—Carmustine—brain cancer	0.000286	0.00192	CcSEcCtD
Sitaxentan—Anorexia—Procarbazine—brain cancer	0.000285	0.00191	CcSEcCtD
Sitaxentan—Infestation NOS—Temozolomide—brain cancer	0.000283	0.0019	CcSEcCtD
Sitaxentan—Infestation—Temozolomide—brain cancer	0.000283	0.0019	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—OR14C36—brain cancer	0.000282	0.00471	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—OR4C12—brain cancer	0.000282	0.00471	CbGpPWpGaD
Sitaxentan—Nausea—Lomustine—brain cancer	0.00028	0.00188	CcSEcCtD
Sitaxentan—Hypotension—Procarbazine—brain cancer	0.000279	0.00187	CcSEcCtD
Sitaxentan—Stomatitis—Temozolomide—brain cancer	0.000276	0.00185	CcSEcCtD
Sitaxentan—Insomnia—Procarbazine—brain cancer	0.00027	0.00181	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Temozolomide—brain cancer	0.000268	0.0018	CcSEcCtD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000267	0.00446	CbGpPWpGaD
Sitaxentan—Sinusitis—Temozolomide—brain cancer	0.000266	0.00178	CcSEcCtD
Sitaxentan—Somnolence—Procarbazine—brain cancer	0.000266	0.00178	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—ABR—brain cancer	0.000266	0.00444	CbGpPWpGaD
Sitaxentan—Cramp muscle—Etoposide—brain cancer	0.000265	0.00178	CcSEcCtD
Sitaxentan—Haemoglobin—Carmustine—brain cancer	0.000265	0.00177	CcSEcCtD
Sitaxentan—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000264	0.0044	CbGpPWpGaD
Sitaxentan—Haemorrhage—Carmustine—brain cancer	0.000263	0.00177	CcSEcCtD
Sitaxentan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000263	0.00176	CcSEcCtD
Sitaxentan—Anaemia—Hydroxyurea—brain cancer	0.000262	0.00176	CcSEcCtD
Sitaxentan—Decreased appetite—Procarbazine—brain cancer	0.00026	0.00174	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Etoposide—brain cancer	0.00026	0.00174	CcSEcCtD
Sitaxentan—Oedema peripheral—Carmustine—brain cancer	0.000259	0.00174	CcSEcCtD
Sitaxentan—Fatigue—Procarbazine—brain cancer	0.000258	0.00173	CcSEcCtD
Sitaxentan—Haemoglobin—Temozolomide—brain cancer	0.000256	0.00171	CcSEcCtD
Sitaxentan—Malaise—Hydroxyurea—brain cancer	0.000256	0.00171	CcSEcCtD
Sitaxentan—Pain—Procarbazine—brain cancer	0.000256	0.00171	CcSEcCtD
Sitaxentan—Constipation—Procarbazine—brain cancer	0.000256	0.00171	CcSEcCtD
Sitaxentan—Haemorrhage—Temozolomide—brain cancer	0.000254	0.00171	CcSEcCtD
Sitaxentan—Hepatitis—Temozolomide—brain cancer	0.000254	0.00171	CcSEcCtD
Sitaxentan—Leukopenia—Hydroxyurea—brain cancer	0.000254	0.0017	CcSEcCtD
Sitaxentan—Visual impairment—Carmustine—brain cancer	0.000254	0.0017	CcSEcCtD
Sitaxentan—Urinary tract disorder—Temozolomide—brain cancer	0.000251	0.00168	CcSEcCtD
Sitaxentan—Oedema peripheral—Temozolomide—brain cancer	0.000251	0.00168	CcSEcCtD
Sitaxentan—Urethral disorder—Temozolomide—brain cancer	0.000249	0.00167	CcSEcCtD
Sitaxentan—Feeling abnormal—Procarbazine—brain cancer	0.000246	0.00165	CcSEcCtD
Sitaxentan—Eye disorder—Carmustine—brain cancer	0.000246	0.00165	CcSEcCtD
Sitaxentan—Visual impairment—Temozolomide—brain cancer	0.000245	0.00164	CcSEcCtD
Sitaxentan—Flushing—Carmustine—brain cancer	0.000244	0.00164	CcSEcCtD
Sitaxentan—Pancytopenia—Etoposide—brain cancer	0.000242	0.00162	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—ABR—brain cancer	0.000241	0.00403	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00024	0.00161	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—DTX2—brain cancer	0.00024	0.004	CbGpPWpGaD
Sitaxentan—Discomfort—Hydroxyurea—brain cancer	0.000239	0.0016	CcSEcCtD
Sitaxentan—Eye disorder—Temozolomide—brain cancer	0.000238	0.00159	CcSEcCtD
Sitaxentan—Urticaria—Procarbazine—brain cancer	0.000238	0.00159	CcSEcCtD
Sitaxentan—Tinnitus—Temozolomide—brain cancer	0.000237	0.00159	CcSEcCtD
Sitaxentan—Body temperature increased—Procarbazine—brain cancer	0.000236	0.00158	CcSEcCtD
Sitaxentan—Cardiac disorder—Temozolomide—brain cancer	0.000236	0.00158	CcSEcCtD
Sitaxentan—Flushing—Temozolomide—brain cancer	0.000236	0.00158	CcSEcCtD
Sitaxentan—Alopecia—Carmustine—brain cancer	0.000233	0.00156	CcSEcCtD
Sitaxentan—Oedema—Hydroxyurea—brain cancer	0.000231	0.00155	CcSEcCtD
Sitaxentan—Angiopathy—Temozolomide—brain cancer	0.000231	0.00155	CcSEcCtD
Sitaxentan—Mental disorder—Carmustine—brain cancer	0.000231	0.00155	CcSEcCtD
Sitaxentan—Infection—Hydroxyurea—brain cancer	0.00023	0.00154	CcSEcCtD
Sitaxentan—Immune system disorder—Temozolomide—brain cancer	0.00023	0.00154	CcSEcCtD
Sitaxentan—Mediastinal disorder—Temozolomide—brain cancer	0.000229	0.00154	CcSEcCtD
Sitaxentan—Malnutrition—Carmustine—brain cancer	0.000229	0.00154	CcSEcCtD
Sitaxentan—Nervous system disorder—Hydroxyurea—brain cancer	0.000227	0.00152	CcSEcCtD
Sitaxentan—Infestation NOS—Etoposide—brain cancer	0.000227	0.00152	CcSEcCtD
Sitaxentan—Infestation—Etoposide—brain cancer	0.000227	0.00152	CcSEcCtD
Sitaxentan—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000227	0.00379	CbGpPWpGaD
Sitaxentan—Thrombocytopenia—Hydroxyurea—brain cancer	0.000227	0.00152	CcSEcCtD
Sitaxentan—Alopecia—Temozolomide—brain cancer	0.000225	0.00151	CcSEcCtD
Sitaxentan—Skin disorder—Hydroxyurea—brain cancer	0.000225	0.00151	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Etoposide—brain cancer	0.000224	0.0015	CcSEcCtD
Sitaxentan—Renal failure—Etoposide—brain cancer	0.000223	0.00149	CcSEcCtD
Sitaxentan—Mental disorder—Temozolomide—brain cancer	0.000223	0.00149	CcSEcCtD
Sitaxentan—Myocardial infarction—Etoposide—brain cancer	0.000222	0.00149	CcSEcCtD
Sitaxentan—Malnutrition—Temozolomide—brain cancer	0.000222	0.00148	CcSEcCtD
Sitaxentan—Jaundice—Etoposide—brain cancer	0.000221	0.00148	CcSEcCtD
Sitaxentan—Stomatitis—Etoposide—brain cancer	0.000221	0.00148	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—SHH—brain cancer	0.000221	0.00369	CbGpPWpGaD
Sitaxentan—Anorexia—Hydroxyurea—brain cancer	0.000221	0.00148	CcSEcCtD
Sitaxentan—Hypersensitivity—Procarbazine—brain cancer	0.00022	0.00148	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PTCH2—brain cancer	0.00022	0.00367	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000216	0.00361	CbGpPWpGaD
Sitaxentan—Tremor—Carmustine—brain cancer	0.000215	0.00144	CcSEcCtD
Sitaxentan—Asthenia—Procarbazine—brain cancer	0.000215	0.00144	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Etoposide—brain cancer	0.000215	0.00144	CcSEcCtD
Sitaxentan—Anaemia—Carmustine—brain cancer	0.000212	0.00142	CcSEcCtD
Sitaxentan—Agitation—Carmustine—brain cancer	0.000211	0.00141	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—SMO—brain cancer	0.000209	0.0035	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—PTCH1—brain cancer	0.000209	0.0035	CbGpPWpGaD
Sitaxentan—Tremor—Temozolomide—brain cancer	0.000208	0.00139	CcSEcCtD
Sitaxentan—Somnolence—Hydroxyurea—brain cancer	0.000206	0.00138	CcSEcCtD
Sitaxentan—Ill-defined disorder—Temozolomide—brain cancer	0.000206	0.00138	CcSEcCtD
Sitaxentan—Leukopenia—Carmustine—brain cancer	0.000205	0.00138	CcSEcCtD
Sitaxentan—Anaemia—Temozolomide—brain cancer	0.000205	0.00137	CcSEcCtD
Sitaxentan—Diarrhoea—Procarbazine—brain cancer	0.000205	0.00137	CcSEcCtD
Sitaxentan—Dyspepsia—Hydroxyurea—brain cancer	0.000204	0.00137	CcSEcCtD
Sitaxentan—Agitation—Temozolomide—brain cancer	0.000204	0.00136	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—OR14C36—brain cancer	0.000202	0.00337	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—OR4C12—brain cancer	0.000202	0.00337	CbGpPWpGaD
Sitaxentan—Decreased appetite—Hydroxyurea—brain cancer	0.000201	0.00135	CcSEcCtD
Sitaxentan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000201	0.00336	CbGpPWpGaD
Sitaxentan—Urinary tract disorder—Etoposide—brain cancer	0.000201	0.00135	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.0002	0.00134	CcSEcCtD
Sitaxentan—Malaise—Temozolomide—brain cancer	0.0002	0.00134	CcSEcCtD
Sitaxentan—Urethral disorder—Etoposide—brain cancer	0.0002	0.00134	CcSEcCtD
Sitaxentan—Fatigue—Hydroxyurea—brain cancer	0.0002	0.00134	CcSEcCtD
Sitaxentan—Vertigo—Temozolomide—brain cancer	0.000199	0.00133	CcSEcCtD
Sitaxentan—Leukopenia—Temozolomide—brain cancer	0.000198	0.00133	CcSEcCtD
Sitaxentan—Pain—Hydroxyurea—brain cancer	0.000198	0.00133	CcSEcCtD
Sitaxentan—Constipation—Hydroxyurea—brain cancer	0.000198	0.00133	CcSEcCtD
Sitaxentan—Dizziness—Procarbazine—brain cancer	0.000198	0.00133	CcSEcCtD
Sitaxentan—Chest pain—Carmustine—brain cancer	0.000195	0.00131	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000191	0.00319	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Hydroxyurea—brain cancer	0.000191	0.00128	CcSEcCtD
Sitaxentan—Eye disorder—Etoposide—brain cancer	0.00019	0.00128	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—ABR—brain cancer	0.00019	0.00317	CbGpPWpGaD
Sitaxentan—Vomiting—Procarbazine—brain cancer	0.00019	0.00127	CcSEcCtD
Sitaxentan—Flushing—Etoposide—brain cancer	0.000189	0.00127	CcSEcCtD
Sitaxentan—Cardiac disorder—Etoposide—brain cancer	0.000189	0.00127	CcSEcCtD
Sitaxentan—Confusional state—Carmustine—brain cancer	0.000189	0.00126	CcSEcCtD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000189	0.00315	CbGpPWpGaD
Sitaxentan—Rash—Procarbazine—brain cancer	0.000189	0.00126	CcSEcCtD
Sitaxentan—Dermatitis—Procarbazine—brain cancer	0.000188	0.00126	CcSEcCtD
Sitaxentan—Headache—Procarbazine—brain cancer	0.000187	0.00126	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000187	0.00126	CcSEcCtD
Sitaxentan—Oedema—Carmustine—brain cancer	0.000187	0.00125	CcSEcCtD
Sitaxentan—Discomfort—Temozolomide—brain cancer	0.000186	0.00125	CcSEcCtD
Sitaxentan—Infection—Carmustine—brain cancer	0.000186	0.00125	CcSEcCtD
Sitaxentan—Angiopathy—Etoposide—brain cancer	0.000185	0.00124	CcSEcCtD
Sitaxentan—Dry mouth—Temozolomide—brain cancer	0.000184	0.00124	CcSEcCtD
Sitaxentan—Immune system disorder—Etoposide—brain cancer	0.000184	0.00123	CcSEcCtD
Sitaxentan—Mediastinal disorder—Etoposide—brain cancer	0.000184	0.00123	CcSEcCtD
Sitaxentan—Thrombocytopenia—Carmustine—brain cancer	0.000183	0.00123	CcSEcCtD
Sitaxentan—Body temperature increased—Hydroxyurea—brain cancer	0.000183	0.00123	CcSEcCtD
Sitaxentan—Tachycardia—Carmustine—brain cancer	0.000183	0.00122	CcSEcCtD
Sitaxentan—Confusional state—Temozolomide—brain cancer	0.000182	0.00122	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PTCH2—brain cancer	0.000182	0.00303	CbGpPWpGaD
Sitaxentan—Oedema—Temozolomide—brain cancer	0.000181	0.00121	CcSEcCtD
Sitaxentan—Alopecia—Etoposide—brain cancer	0.00018	0.00121	CcSEcCtD
Sitaxentan—Infection—Temozolomide—brain cancer	0.00018	0.0012	CcSEcCtD
Sitaxentan—Anorexia—Carmustine—brain cancer	0.000178	0.0012	CcSEcCtD
Sitaxentan—Nausea—Procarbazine—brain cancer	0.000178	0.00119	CcSEcCtD
Sitaxentan—Nervous system disorder—Temozolomide—brain cancer	0.000177	0.00119	CcSEcCtD
Sitaxentan—Thrombocytopenia—Temozolomide—brain cancer	0.000177	0.00119	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HES5—brain cancer	0.000176	0.00294	CbGpPWpGaD
Sitaxentan—Skin disorder—Temozolomide—brain cancer	0.000176	0.00118	CcSEcCtD
Sitaxentan—Hypotension—Carmustine—brain cancer	0.000175	0.00117	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—ABR—brain cancer	0.000173	0.00288	CbGpPWpGaD
Sitaxentan—Anorexia—Temozolomide—brain cancer	0.000172	0.00116	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—DTX2—brain cancer	0.000172	0.00286	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STRADA—brain cancer	0.000171	0.00285	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Hydroxyurea—brain cancer	0.00017	0.00114	CcSEcCtD
Sitaxentan—Muscle spasms—Etoposide—brain cancer	0.00017	0.00114	CcSEcCtD
Sitaxentan—Insomnia—Carmustine—brain cancer	0.000169	0.00113	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—TRPC6—brain cancer	0.000168	0.00281	CbGpPWpGaD
Sitaxentan—Somnolence—Carmustine—brain cancer	0.000166	0.00111	CcSEcCtD
Sitaxentan—Asthenia—Hydroxyurea—brain cancer	0.000166	0.00111	CcSEcCtD
Sitaxentan—Ill-defined disorder—Etoposide—brain cancer	0.000164	0.0011	CcSEcCtD
Sitaxentan—Anaemia—Etoposide—brain cancer	0.000164	0.0011	CcSEcCtD
Sitaxentan—Insomnia—Temozolomide—brain cancer	0.000164	0.0011	CcSEcCtD
Sitaxentan—Decreased appetite—Carmustine—brain cancer	0.000163	0.00109	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Carmustine—brain cancer	0.000162	0.00108	CcSEcCtD
Sitaxentan—Somnolence—Temozolomide—brain cancer	0.000161	0.00108	CcSEcCtD
Sitaxentan—Pain—Carmustine—brain cancer	0.00016	0.00107	CcSEcCtD
Sitaxentan—Constipation—Carmustine—brain cancer	0.00016	0.00107	CcSEcCtD
Sitaxentan—Malaise—Etoposide—brain cancer	0.00016	0.00107	CcSEcCtD
Sitaxentan—Vertigo—Etoposide—brain cancer	0.000159	0.00107	CcSEcCtD
Sitaxentan—Dyspepsia—Temozolomide—brain cancer	0.000159	0.00107	CcSEcCtD
Sitaxentan—Leukopenia—Etoposide—brain cancer	0.000159	0.00106	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—SHH—brain cancer	0.000158	0.00264	CbGpPWpGaD
Sitaxentan—Diarrhoea—Hydroxyurea—brain cancer	0.000158	0.00106	CcSEcCtD
Sitaxentan—Decreased appetite—Temozolomide—brain cancer	0.000157	0.00105	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Temozolomide—brain cancer	0.000156	0.00105	CcSEcCtD
Sitaxentan—Fatigue—Temozolomide—brain cancer	0.000156	0.00104	CcSEcCtD
Sitaxentan—Pain—Temozolomide—brain cancer	0.000155	0.00104	CcSEcCtD
Sitaxentan—Constipation—Temozolomide—brain cancer	0.000155	0.00104	CcSEcCtD
Sitaxentan—Feeling abnormal—Carmustine—brain cancer	0.000154	0.00103	CcSEcCtD
Sitaxentan—Dizziness—Hydroxyurea—brain cancer	0.000153	0.00103	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—TRPC6—brain cancer	0.000153	0.00255	CbGpPWpGaD
Sitaxentan—Chest pain—Etoposide—brain cancer	0.000151	0.00101	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—SMO—brain cancer	0.00015	0.00251	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PTCH1—brain cancer	0.00015	0.00251	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00015	0.001	CcSEcCtD
Sitaxentan—Discomfort—Etoposide—brain cancer	0.000149	0.000999	CcSEcCtD
Sitaxentan—Feeling abnormal—Temozolomide—brain cancer	0.000149	0.000999	CcSEcCtD
Sitaxentan—Body temperature increased—Carmustine—brain cancer	0.000148	0.000991	CcSEcCtD
Sitaxentan—Vomiting—Hydroxyurea—brain cancer	0.000147	0.000986	CcSEcCtD
Sitaxentan—Rash—Hydroxyurea—brain cancer	0.000146	0.000978	CcSEcCtD
Sitaxentan—Confusional state—Etoposide—brain cancer	0.000146	0.000978	CcSEcCtD
Sitaxentan—Dermatitis—Hydroxyurea—brain cancer	0.000146	0.000977	CcSEcCtD
Sitaxentan—Headache—Hydroxyurea—brain cancer	0.000145	0.000972	CcSEcCtD
Sitaxentan—Infection—Etoposide—brain cancer	0.000144	0.000963	CcSEcCtD
Sitaxentan—Urticaria—Temozolomide—brain cancer	0.000144	0.000963	CcSEcCtD
Sitaxentan—Body temperature increased—Temozolomide—brain cancer	0.000143	0.000958	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ABR—brain cancer	0.000143	0.00238	CbGpPWpGaD
Sitaxentan—Thrombocytopenia—Etoposide—brain cancer	0.000142	0.000949	CcSEcCtD
Sitaxentan—Tachycardia—Etoposide—brain cancer	0.000141	0.000946	CcSEcCtD
Sitaxentan—Skin disorder—Etoposide—brain cancer	0.000141	0.000942	CcSEcCtD
Sitaxentan—Anorexia—Etoposide—brain cancer	0.000138	0.000924	CcSEcCtD
Sitaxentan—Hypersensitivity—Carmustine—brain cancer	0.000138	0.000924	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—GLI2—brain cancer	0.000138	0.0023	CbGpPWpGaD
Sitaxentan—Nausea—Hydroxyurea—brain cancer	0.000137	0.000921	CcSEcCtD
Sitaxentan—Hypotension—Etoposide—brain cancer	0.000135	0.000906	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000135	0.00226	CbGpPWpGaD
Sitaxentan—Asthenia—Carmustine—brain cancer	0.000134	0.0009	CcSEcCtD
Sitaxentan—Hypersensitivity—Temozolomide—brain cancer	0.000133	0.000893	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PTCH2—brain cancer	0.00013	0.00217	CbGpPWpGaD
Sitaxentan—Asthenia—Temozolomide—brain cancer	0.00013	0.000869	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—GLI1—brain cancer	0.000129	0.00216	CbGpPWpGaD
Sitaxentan—Somnolence—Etoposide—brain cancer	0.000129	0.000862	CcSEcCtD
Sitaxentan—Diarrhoea—Carmustine—brain cancer	0.000128	0.000858	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—VAV1—brain cancer	0.000126	0.0021	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HES5—brain cancer	0.000126	0.0021	CbGpPWpGaD
Sitaxentan—Decreased appetite—Etoposide—brain cancer	0.000126	0.000843	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Etoposide—brain cancer	0.000125	0.000837	CcSEcCtD
Sitaxentan—Fatigue—Etoposide—brain cancer	0.000125	0.000836	CcSEcCtD
Sitaxentan—Dizziness—Carmustine—brain cancer	0.000124	0.000829	CcSEcCtD
Sitaxentan—Constipation—Etoposide—brain cancer	0.000124	0.000829	CcSEcCtD
Sitaxentan—Pain—Etoposide—brain cancer	0.000124	0.000829	CcSEcCtD
Sitaxentan—Diarrhoea—Temozolomide—brain cancer	0.000124	0.000829	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—SUFU—brain cancer	0.000123	0.00205	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STRADA—brain cancer	0.000122	0.00204	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—TRPC6—brain cancer	0.00012	0.00201	CbGpPWpGaD
Sitaxentan—Dizziness—Temozolomide—brain cancer	0.00012	0.000801	CcSEcCtD
Sitaxentan—Feeling abnormal—Etoposide—brain cancer	0.000119	0.000799	CcSEcCtD
Sitaxentan—Vomiting—Carmustine—brain cancer	0.000119	0.000797	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—GFAP—brain cancer	0.000118	0.00198	CbGpPWpGaD
Sitaxentan—Rash—Carmustine—brain cancer	0.000118	0.000791	CcSEcCtD
Sitaxentan—Dermatitis—Carmustine—brain cancer	0.000118	0.00079	CcSEcCtD
Sitaxentan—Headache—Carmustine—brain cancer	0.000117	0.000786	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000115	0.00192	CbGpPWpGaD
Sitaxentan—Vomiting—Temozolomide—brain cancer	0.000115	0.000771	CcSEcCtD
Sitaxentan—Urticaria—Etoposide—brain cancer	0.000115	0.00077	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—VAV1—brain cancer	0.000114	0.00191	CbGpPWpGaD
Sitaxentan—Body temperature increased—Etoposide—brain cancer	0.000114	0.000767	CcSEcCtD
Sitaxentan—Rash—Temozolomide—brain cancer	0.000114	0.000764	CcSEcCtD
Sitaxentan—Dermatitis—Temozolomide—brain cancer	0.000114	0.000763	CcSEcCtD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000113	0.00189	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—SHH—brain cancer	0.000113	0.00189	CbGpPWpGaD
Sitaxentan—Headache—Temozolomide—brain cancer	0.000113	0.000759	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HEY1—brain cancer	0.000112	0.00187	CbGpPWpGaD
Sitaxentan—Nausea—Carmustine—brain cancer	0.000111	0.000745	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—DLL1—brain cancer	0.00011	0.00184	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TRPC6—brain cancer	0.000109	0.00182	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PTCH1—brain cancer	0.000107	0.00179	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—SMO—brain cancer	0.000107	0.00179	CbGpPWpGaD
Sitaxentan—Nausea—Temozolomide—brain cancer	0.000107	0.00072	CcSEcCtD
Sitaxentan—Hypersensitivity—Etoposide—brain cancer	0.000107	0.000714	CcSEcCtD
Sitaxentan—Asthenia—Etoposide—brain cancer	0.000104	0.000696	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—ABR—brain cancer	0.000102	0.0017	CbGpPWpGaD
Sitaxentan—Diarrhoea—Etoposide—brain cancer	9.9e-05	0.000663	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—GLI2—brain cancer	9.85e-05	0.00164	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	9.67e-05	0.00161	CbGpPWpGaD
Sitaxentan—Dizziness—Etoposide—brain cancer	9.57e-05	0.000641	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—SHH—brain cancer	9.36e-05	0.00156	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GLI1—brain cancer	9.26e-05	0.00155	CbGpPWpGaD
Sitaxentan—Vomiting—Etoposide—brain cancer	9.2e-05	0.000617	CcSEcCtD
Sitaxentan—Rash—Etoposide—brain cancer	9.12e-05	0.000611	CcSEcCtD
Sitaxentan—Dermatitis—Etoposide—brain cancer	9.11e-05	0.000611	CcSEcCtD
Sitaxentan—Headache—Etoposide—brain cancer	9.06e-05	0.000607	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—TRPC6—brain cancer	9.02e-05	0.00151	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—VAV1—brain cancer	9.02e-05	0.00151	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTCH1—brain cancer	8.87e-05	0.00148	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SMO—brain cancer	8.87e-05	0.00148	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SUFU—brain cancer	8.78e-05	0.00147	CbGpPWpGaD
Sitaxentan—Nausea—Etoposide—brain cancer	8.59e-05	0.000576	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—GFAP—brain cancer	8.47e-05	0.00141	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—VAV1—brain cancer	8.19e-05	0.00137	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HEY1—brain cancer	8.03e-05	0.00134	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PIK3CG—brain cancer	8e-05	0.00134	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DLL1—brain cancer	7.88e-05	0.00131	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.34e-05	0.00123	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CG—brain cancer	7.27e-05	0.00121	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH2—brain cancer	7.09e-05	0.00118	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VAV1—brain cancer	6.76e-05	0.00113	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SHH—brain cancer	6.7e-05	0.00112	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TRPC6—brain cancer	6.46e-05	0.00108	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SMO—brain cancer	6.35e-05	0.00106	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTCH1—brain cancer	6.35e-05	0.00106	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HES1—brain cancer	5.82e-05	0.000971	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CG—brain cancer	5.73e-05	0.000956	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—brain cancer	5.63e-05	0.00094	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PDGFRA—brain cancer	5.54e-05	0.000924	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SPP1—brain cancer	5.38e-05	0.000897	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.37e-05	0.000896	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CG—brain cancer	5.2e-05	0.000868	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—brain cancer	5.11e-05	0.000854	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH2—brain cancer	5.08e-05	0.000847	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.9e-05	0.000817	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IRS2—brain cancer	4.86e-05	0.000811	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VAV1—brain cancer	4.84e-05	0.000808	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APC—brain cancer	4.29e-05	0.000717	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CG—brain cancer	4.29e-05	0.000717	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HES1—brain cancer	4.16e-05	0.000695	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—brain cancer	4.03e-05	0.000673	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDGFRA—brain cancer	3.96e-05	0.000661	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EGFR—brain cancer	3.91e-05	0.000653	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SPP1—brain cancer	3.85e-05	0.000642	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—brain cancer	3.66e-05	0.000611	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IRS2—brain cancer	3.48e-05	0.000581	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RELA—brain cancer	3.35e-05	0.00056	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ERBB2—brain cancer	3.33e-05	0.000556	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2C9—brain cancer	3.27e-05	0.000546	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APC—brain cancer	3.07e-05	0.000513	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CG—brain cancer	3.07e-05	0.000513	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—brain cancer	3.02e-05	0.000504	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCND1—brain cancer	2.95e-05	0.000492	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CTNNB1—brain cancer	2.92e-05	0.000487	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—brain cancer	2.8e-05	0.000467	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BSG—brain cancer	2.78e-05	0.000464	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—brain cancer	2.57e-05	0.000429	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—brain cancer	2.54e-05	0.000424	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BSG—brain cancer	2.54e-05	0.000423	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RELA—brain cancer	2.4e-05	0.000401	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—IDH1—brain cancer	2.39e-05	0.000399	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ERBB2—brain cancer	2.39e-05	0.000398	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MYC—brain cancer	2.36e-05	0.000394	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—brain cancer	2.31e-05	0.000386	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—IDH1—brain cancer	2.18e-05	0.000364	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—brain cancer	2.16e-05	0.000361	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCND1—brain cancer	2.11e-05	0.000352	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CTNNB1—brain cancer	2.09e-05	0.000348	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2C9—brain cancer	1.97e-05	0.000328	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.95e-05	0.000325	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—brain cancer	1.94e-05	0.000324	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO2—brain cancer	1.89e-05	0.000315	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—brain cancer	1.84e-05	0.000307	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—brain cancer	1.82e-05	0.000304	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.78e-05	0.000296	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO2—brain cancer	1.72e-05	0.000288	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MYC—brain cancer	1.69e-05	0.000282	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BSG—brain cancer	1.67e-05	0.000279	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—brain cancer	1.65e-05	0.000276	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—IDH1—brain cancer	1.44e-05	0.00024	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—brain cancer	1.39e-05	0.000232	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO2—brain cancer	1.14e-05	0.00019	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CG—brain cancer	8.67e-06	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CG—brain cancer	7.91e-06	0.000132	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CG—brain cancer	5.21e-06	8.7e-05	CbGpPWpGaD
